Evidence-Based Management Guidelines on Peyronie's Disease
Abstract
Introduction Despite recent advances in our knowledge and treatment strategies in Peyronie's Disease (PD), much remained unknown about this disease. Aim To provide a clinical framework and key guideline statements to assist clinicians in an evidence-based management of PD. Methods A systematic literature search was conducted to identify published literature relevant to PD. The search included all relevant articles published up to June 2015, including preclinical studies and published guidelines. References used in the text were assessed according to their level of evidence, and guideline recommendations were graded based on the Oxford Centre for Evidence-Based Medicine Levels of Evidence. Owing to the paucity of larger series and randomized placebo-controlled trials with regard to surgical intervention, guideline statements are provided as clinical principle or expert opinion. Main outcome measures This literature was discussed at a panel meeting, and selected articles with the highest evidence available were used to create consensus guideline statements for the Fourth International Consultation on Sexual Medicine guidelines on PD. Results In addition to existing Third International Consultation on Sexual Medicine guidelines on PD, seven new summary recommendations were created. Conclusion A greater understanding of the scientific basis of PD is greatly needed to address our understanding of the pathophysiology, clinical epidemiology, psychosocial, and diagnostic assessment a…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The CUA endorses a good home photograph with protractor measurement as a less accurate alternative for curvature evaluation.
“The CUA endorses the use of an adequate home photograph with protractor-estimate of penile angulation as an alternative (less accurate) approach to evaluate curvature.28”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The EAU and ISSM guidelines list medical conditions associated with PD, including Dupuytren's contracture, diabetes, hypertension, lipid disease, ischemic cardiomyopathy, ED, low testosterone, pelvic surgery, and tobacco or alcohol use.
“EAU and ISSM guidelines describe specific medical comorbidities that have been associated with PD such as Dupuytren’s contracture, diabetes, hypertension, lipid disease, ischemic cardiomyopathy, ED, low testosterone, pelvic surgery, as well as tobacco and alcohol use.28, 29”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
AUA and ISSM recommend ICI but suggest home photography may be sufficient in some cases.
“The AUA and ISSM guideline panels recommend ICI, but hedge by suggesting that home photography may be “sufficient” in some cases.1, 28”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
Guidelines differ on how many months after symptom onset define stable disease, from six months in CUA and ISSM to more than 12 months in AUA.
“In contrast, there is discrepancy regarding the number of months since symptom onset that defines stable disease, ranging from six-months (CUA, ISSM) to greater than 12-months (AUA).1, 26, 28”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
A careful history and physical examination is required and may be enough for diagnosis, according to expert opinion from AUA, CUA, and ISSM.
“A careful history and physical examination is mandated and may be all that is needed to make the diagnosis based on expert opinion from the AUA, CUA, and ISSM panels.1, 26, 28”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The AUA, ISSM, CUA, and EAU each issued a PD clinical guideline in the five years before this review.
“Within the last five years clinical guidelines were published by the American Urological Association (AUA), International Society for Sexual Medicine (ISSM), Canadian Urological Association (CUA), and the European Association of Urology (EAU).26–29”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The ISSM guideline stresses that grafting surgeries should be done by experts.
“Specifically citing the complexity of grafting surgeries, ISSM again emphasizes that these should be performed by experts.28”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
No guideline requires routine use of these questionnaires, but ISSM specifically emphasizes PDQ for baseline data and monitoring treatment outcomes.
“No guideline mandates the routine use of these questionnaires, although the ISSM guideline panel explicitly emphasizes the PDQ to establish baseline data and monitor treatment outcomes.28”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The ISSM underscores lack of proven benefit for iontophoresis and suggests that curvature decrease in some series may be due to energy delivered to tissue.
“the ISSM guideline panel underscores the lack of proven benefit and suggests that the decrease in curvature seen in some series may be due to the energy delivered to the tissue.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
All panels acknowledge these psychosocial concerns and stress assessing psychological burden with subjective and objective measures, including the PDQ symptom-bother domain.
“These concerns are acknowledged by all guideline panels with emphasis placed on assessing psychological burden through subjective and objective measures, including the PDQ which has a specific domain pertaining to symptom bother.1, 26, 28, 29”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The ISSM does not recommend any oral therapy as primary treatment for Peyronie's disease because of lack of proven benefit in rigorous clinical studies.
“The ISSM guideline does not recommend any oral therapy as primary treatment due to the lack of proven benefit in rigorous clinical studies to date.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The ISSM guideline group aligns with the AUA recommendations on mechanical therapies.
“This is line with recommendations by the ISSM guideline group as well.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The ISSM guideline describes a similar stance on intralesional verapamil.
“A similar stance is described within the ISSM guideline.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The EAU, AUA, and CUA emphasize lack of robust evidence for hyaluronic acid and botulinum toxin therapy in Peyronie's disease.
“The EAU, AUA, and CUA also emphasize the lack of robust evidence to support hyaluronic acid and botulinum toxin therapy for PD.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
CUA, EAU, and ISSM discourage MRI, CT, and plain-film X-ray because they lack proven efficacy and involve expense and radiation.
“Other imaging modalities including MRI, CT, and plain-film XRAY are discouraged by the CUA, EAU, and ISSM guideline panels given their lack of proven efficacy, expense, and radiation exposure.26, 28”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
AUA, CUA, and ISSM support PD/PDDU as optional for evaluating plaque characteristics and penile hemodynamics.
“In contrast, AUA, CUA, and ISSM guideline panels support PD/PDDU as optional to evaluate plaque characteristics and penile hemodynamics.126, 28”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The CUA, EAU, and ISSM suggest plaque incision with grafting be reserved for men with more severe penile deformity.
“The CUA, EAU, and ISSM guideline panels suggest that plaque incision with grafting be reserved for men with more severe penile deformity.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The ISSM and recent EAU guidelines outline similar algorithms for adjunctive procedures with inflatable penile prosthesis placement, based on this and other earlier publications.
“ISSM and the recent EAU guidelines both outline similar algorithms for the adjunctive procedures often employed with IPP placement, based on this and other earlier publications.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The CUA and ISSM consider isolated hourglass deformity and severe plaque calcification as exclusion criteria for collagenase clostridium histolyticum.
“The CUA and ISSM guideline panels consider isolated hourglass deformity and severe plaque calcification as exclusion criteria for CCH.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The ISSM recommends grafting over the defect if a defect greater than 2 cm results.
“Per the ISSM guideline, grafting over the defect is recommended if a defect >2 cm results.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The CUA, EAU, and ISSM strongly recommend against synthetic grafts because of adverse outcomes including persistent or recurrent fibrosis and infection.
“The CUA, EAU, and ISSM panels recommend strongly against synthetic grafts as they have been associated with adverse outcomes including persistent/recurrent fibrosis and infection.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The EAU, CUA, and ISSM emphasize the concept of a functionally straight penis, within 20 degrees of straight rather than arrow straight.
“The EAU, CUA, and ISSM panels specifically emphasize the concept of a “functionally” straight penis (i.e. within 20o of straight as opposed to “arrow” straight).”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The ISSM suggests stable Peyronie's disease symptoms for at least 6 months before surgery, while the AUA indicates symptom duration of at least 12 months with 3 to 6 months of symptom stability.
“the ISSM panel suggests that patients should have stable PD symptoms for at least 6 months prior to surgery as compared to the AUA which indicates symptom duration of at least 12 months with 3–6 months of symptom stability.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The ISSM highlights traction combined with PDE5 inhibitors as an option for penile rehabilitation.
“ISSM also highlights traction in combination with PDE-5i as an option for penile rehabilitation.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
The PDQ is considered an adjunctive evaluation tool by the CUA and ISSM, and the EAU recommends it during initial assessment and follow-up to determine treatment efficacy beyond objective measurements.
“The PDQ is considered an adjunctive evaluation tool by the CUA and ISSM, and the EAU now recommends this tool during the initial assessment and subsequent follow-up to determine treatment efficacy beyond simple objective measurements.”
From Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation. (2021) · cites this paper as [28]
Cites
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290 · see citing works
Proposal: Trauma as the Cause of the Peyronie's Lesion
Devine, C. J. J., Somers, K. D., Jordan, G. H., & Schlossberg, S. M. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65361-8 · Cited by 381 · see citing works
El-Sakka, A. I., Hassoba, H. M., Pillarisetty, R. J., Dahiya, R., & Lue, T. F. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64223-x · Cited by 250 · cited 2× · see citing works
“It is hypothesized that after an injury to the erect penis, there is localized disruption of the penile TA and an ensuing increase in microvascular permeability with the release of various cytokines and growth factors, with transforming growth factor-b1 (TGF-b1) identified as the predominant pro-fibrotic factor in the…”
BackgroundHellstrom, W. J. G., Feldman, R., Rosen, R. C., Smith, T., Kaufman, G., & Tursi, J. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.01.090 · Cited by 210 · see citing works
Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease
Gonzalez-Cadavid, N. F., & Rajfer, J. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0201 · Cited by 168 · see citing works
Levine, L., & Dimitriou, R. (2000) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900515 · Cited by 113 · see citing works
Mulhall, J. P., Nicholson, B., Pierpaoli, S., Lubrano, T., & Shankey, T. V. (2004) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901170 · Cited by 43 · see citing works
Hauck, E. W., Hauptmann, A., Haag, S. M., Bohnert, A., Weidner, W., Bein, G., & Hackstein, H. (2004) · European Urology · doi:10.1016/j.eururo.2004.04.028 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Salonia, A., Capogrosso, P., Boeri, L., Cocci, A., Corona, G., Dinkelman-Smit, M., Falcone, M., Jensen, C. F., Gül, M., Kalkanli, A., et al. (2025) · European Urology · doi:10.1016/j.eururo.2025.04.010 · Cited by 174 · see citing works
Bella, A. J., Lee, J. C., Grober, E. D., Carrier, S., Benard, F., & Brock, G. B. (2018) · Canadian Urological Association Journal · doi:10.5489/cuaj.5255 · Cited by 68 · see citing works
Nonsurgical management of Peyronie’s disease
Tsambarlis, P., & Levine, L. A. (2019) · Nature Reviews Urology · doi:10.1038/s41585-018-0117-7 · Cited by 64 · see citing works
Comparing and Contrasting Peyronie's Disease Guidelines: Points of Consensus and Deviation.
Manka, M. G., White, L. A., Yafi, F. A., Mulhall, J. P., Levine, L. A., & Ziegelmann, M. J. (2021) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.11.013 · Cited by 28 · see citing works
Sokolakis, I., Pyrgidis, N., Ziegelmann, M. J., Mykoniatis, I., Köhler, T. S., & Hatzichristodoulou, G. (2022) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2021.03.007 · Cited by 27 · see citing works
Paulis, G., De Giorgio, G., & Paulis, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415969 · Cited by 21 · see citing works
Glimpses into the molecular pathogenesis of Peyronie’s disease
ten Dam, E.-J. P. M., van Driel, M. F., de Jong, I. J., Werker, P. M. N., & Bank, R. A. (2020) · The Aging Male · doi:10.1080/13685538.2019.1643311 · Cited by 15 · see citing works
“In a recently published guideline on PD, one of the major conclusions was that a greater understanding of the pathophysiology is necessary to provide better diagnostic and therapeutic options for PD patients [24].”
BackgroundClinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases
Paulis, G., De Giorgio, G., & Paulis, A. (2024) · Diagnostics · doi:10.3390/diagnostics14111125 · Cited by 11 · see citing works
Wang, X., Liu, H., Tang, G., Wu, G., Chu, Y., Wu, J., & Cui, Y. (2023) · BMC Urology · doi:10.1186/s12894-023-01320-8 · Cited by 9 · see citing works
- Authors
- Chung, E., Ralph, D., Kagioglu, A., Garaffa, G., Shamsodini, A., Bivalacqua, T., Glina, S., Hakim, L., Sadeghi-Nejad, H., & Broderick, G.
- Affiliations
- The University of Queensland (AU)
- University College Hospital (GB)
- Istanbul University (TR)
- Urology Department , Doha, , Qatar
- Johns Hopkins University (US)
- Instituto H. Ellis (BR)
- Cleveland Clinic Florida (US)
- Division of Urology , Newark, NJ , USA
- Mayo Clinic (US)
- Corresponding author
- Chung, Eric
- Venue
- The Journal of Sexual Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-06-01
- Volume
- 13
- Issue
- 6
- Pages
- 905-923
- ISSN
- 1743-6095 (ISSN-L)
- 1743-6109
- OpenAlex
- W2408545341
- Cited by
- 227
- References
- 8
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 21 · 2023: 25 · 2022: 23 · 2021: 29 · 2020: 27 · 2019: 24 · 2018: 26 · 2017: 19 · 2016: 1 · 2012: 1
- FWCI
- 20.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- The Journal of Sexual Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Keywords
- Peyronie's disease, clinical management guidelines, evidence-based medicine, surgical treatment, pathophysiology, clinical epidemiology, psychosocial aspects, diagnostic assessment, treatment options
- MeSH terms
- Humans, Male, Penile Induration, Practice Guidelines as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review